Angelini Ventures
Headquarter
Basel, Switzerland
Milestones
Founded: 2017
Invested: 2025
CO-Founder and CEO
Leila Jaafar Ph.D
Vertical
Biotech
Board Participation
Regina Hodits, Board Member
Nuclidium is setting a new standard in the precision oncology landscape by developing best-in-class copper-based radiopharmaceuticals that enable the highest accuracy and accessibility for targeted cancer treatment and diagnosis.